Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2010 1
2011 1
2012 1
2014 1
2015 5
2016 3
2017 3
2018 7
2019 2
2020 7
2021 8
2022 5
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Regulation of HOX gene expression in AML.
Khan I, Amin MA, Eklund EA, Gartel AL. Khan I, et al. Blood Cancer J. 2024 Mar 7;14(1):42. doi: 10.1038/s41408-024-01004-y. Blood Cancer J. 2024. PMID: 38453907 Free PMC article. Review.
Myeloid leukemia in Down syndrome.
Khan I, Malinge S, Crispino J. Khan I, et al. Crit Rev Oncog. 2011;16(1-2):25-36. doi: 10.1615/critrevoncog.v16.i1-2.40. Crit Rev Oncog. 2011. PMID: 22150305 Free PMC article. Review.
Honokiol is a FOXM1 antagonist.
Halasi M, Hitchinson B, Shah BN, Váraljai R, Khan I, Benevolenskaya EV, Gaponenko V, Arbiser JL, Gartel AL. Halasi M, et al. Among authors: khan i. Cell Death Dis. 2018 Jan 24;9(2):84. doi: 10.1038/s41419-017-0156-7. Cell Death Dis. 2018. PMID: 29367668 Free PMC article.
The antagonistic duality of NPM1 mutations in AML.
Khan I, Gartel AL. Khan I, et al. Blood Adv. 2022 Jul 12;6(13):4028-4030. doi: 10.1182/bloodadvances.2022007420. Blood Adv. 2022. PMID: 35507748 Free PMC article. No abstract available.
Targeting lipid-protein interaction to treat Syk-mediated acute myeloid leukemia.
Singaram I, Sharma A, Pant S, Lihan M, Park MJ, Pergande M, Buwaneka P, Hu Y, Mahmud N, Kim YM, Cologna S, Gevorgyan V, Khan I, Tajkhorshid E, Cho W. Singaram I, et al. Among authors: khan i. Nat Chem Biol. 2023 Feb;19(2):239-250. doi: 10.1038/s41589-022-01150-z. Epub 2022 Oct 13. Nat Chem Biol. 2023. PMID: 36229686 Free PMC article.
Structural racism is a mediator of disparities in acute myeloid leukemia outcomes.
Abraham IE, Rauscher GH, Patel AA, Pearse WB, Rajakumar P, Burkart M, Aleem A, Dave A, Bharadwaj S, Paydary K, Acevedo-Mendez M, Goparaju K, Gomez R, Carlson K, Tsai SB, Quigley JG, Galvin JP, Zia M, Larson ML, Berg S, Stock W, Altman JK, Khan I. Abraham IE, et al. Among authors: khan i. Blood. 2022 Apr 7;139(14):2212-2226. doi: 10.1182/blood.2021012830. Blood. 2022. PMID: 35061876 Free PMC article.
Extended treatment response to imatinib in Rosai-Dorfman disease.
Singh A, Simons Y, Biren-Fetz J, Mohapatra G, Ni H, Gaitonde S, Khan I. Singh A, et al. Among authors: khan i. Eur J Haematol. 2021 Jun;106(6):868-870. doi: 10.1111/ejh.13605. Epub 2021 Mar 4. Eur J Haematol. 2021. PMID: 33619765 No abstract available.
49 results